Person

Heisz Leslie Stone

Director, Edwards Lifesciences

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$7.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Dec 12, 2025EWSale2,615$83.41$218K
Feb 13, 2025EWSale5,739$75.86$435K
Feb 8, 2024EWSale7,056$86.45$610K
Aug 10, 2023EWSale3,303$78.87$261K
Feb 16, 2023EWSale9,671$76.82$743K
Dec 15, 2021PSASale9,045$362.26$3.3M
Aug 20, 2021PSASale3,957$323.70$1.3M
Apr 23, 2021EWSale6,707$97.52$654K

SEC reporting-owner ID (CIK) 1235408 · all filings on EDGAR